ATLANTA, Feb. 1, 2011 /PRNewswire/ — CryoLife, Inc. (NYSE:
CRY), an implantable biological medical device and
cardiovascular tissue processing company, announced today that 2010
fourth quarter and year end financial results will be released on
Thursday, February 17, 2011. On that day, the Company will
hold a teleconference call and live webcast at 10:00 a.m. Eastern
Time to discuss the results, followed by a question and answer
session hosted by Steven G. Anderson, president and chief executive
officer of CryoLife, Inc.
To listen to the live teleconference, please dial 201-689-8261 a
few minutes prior to 10:00 a.m. A replay of the
teleconference will be available February 17 through February 24
and can be accessed by calling (toll free) 877-660-6853 or
201-612-7415. The account number for the replay is 244 and
the conference number is 366315.
The live webcast and replay can be accessed by going to the
Investor Relations section of the CryoLife web site at www.cryolife.com and selecting
the heading Webcasts & Presentations.
About CryoLife, Inc.Founded in 1984, CryoLife, Inc. is a
leader in the processing and distribution of implantable living
human tissues for use in cardiac and vascular surgeries throughout
the U.S. and Canada. The Company’s CryoValve® SG
pulmonary heart valve, processed using CryoLife’s proprietary
SynerGraft® technology, has FDA 510(k) clearance for the
replacement of diseased, damaged, malformed, or malfunctioning
native or prosthetic pulmonary valves. The Company’s
CryoPatch® SG pulmonary cardiac patch has FDA 510(k) clearance
for the repair or reconstruction of the right ventricular outflow
tract (RVOT), which is a surgery commonly performed in children
with congenital heart defects, such as Tetralogy of Fallot, Truncus
Arteriosus, and Pulmonary Atr
‘/>”/>
